Identification of Pancreatic Exocrinopathy in Non-Obese Diabetic Mice by Gene Subtraction Analysis

Abstract

Type 1 diabetes is an immune-mediated disease with pancreatic infiltration and subsequent beta cell destruction. In this study pancreatic exocrinopathy in non-obese diabetic mice (NOD) was identified using gene subtraction methods (SSH) and macroarray analysis. Female NOD mice were treated with cyclophosphamide for acceleration and synchronization of the disease process at 70 d of age and analysed 10 d later, before the onset of overt diabetes. Extraction of total RNA of pancreas was followed by subtraction using the SSH technique. Pools of cDNA were generated using total RNA from treated and untreated NOD mice. Subtraction of cDNA pools of cyclophosphamide treated mice from cDNA pools of untreated mice resulted in a cDNA library, from which 480 clones were randomly selected. The clones were hybridized against labelled cDNA-probes generated from cyclophosphamide-treated and control NOD mice. Fifty-three clones (11 %) revealed at least twofold differential gene expression after cyclophosphamide treatment.

Three of the downregulated genes (amylase, carboxypeptidase and preprotrypsin) were selected for evaluation of macroarray data by quantitative real-time PCR. Analysis of real-time PCR data confirmed suppression of gene expression with highest fold change for amylase (4.68-fold) followed by carboxypeptidase (2.79-fold) and preprotrypsin (2.14-fold).

These results lead to the conclusion that inflammation in this animal model of type 1 diabetes is not restricted to pancreatic islets and that subtraction followed by macroarray analysis is capable of identifying genes responsible associated with disease progression.

Key words

Mice - pancreas - RNA - expression profile - SSH

References

• 1 Atkinson M A, Maclaren N K. The pathogenesis of insulin-dependent diabetes mellitus.  N Engl J Med. 1994;  331 1428-1436
• 2 Baeza N, Sanchez D, Christa L, Guy-Crotte O, Vialettes B, Figarella C. Pancreatitis-associated protein (HIP/PAP) gene expression is upregulated in NOD mice pancreas and localized in exocrine tissue during diabetes.  Digestion. 2001;  64 233-239
• 3 Diatchenko L, Lau Y F, Campbell A P, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov E D, Siebert P D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.  Proc Natl Acad Sci U S A. 1996;  93 6025-6030
• 4 Faust A, Burkart V, Ulrich H, Weischer C H, Kolb H. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice.  Int J Immunopharmacol. 1994;  16 61-66
• 5 Gurskaya N G, Diatchenko L, Chenchik A, Siebert P D, Khaspekov G L, Lukyanov K A, Vagner L L, Ermolaeva O D, Lukyanov S A, Sverdlov E D. Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate.  Anal Biochem. 1996;  240 90-97
• 6 Harada M, Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide.  Diabetologia. 1984;  27 604-606
• 7 Hardt P D, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klor H U. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.  Pancreatology. 2002;  2 30-33
• 8 Hardt P D, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E, Bretzel R G, Zekhorn T, Klor H U. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus.  Acta Diabetol. 2000;  37 105-110
• 9 Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.  N Engl J Med. 2000;  342 301-307
• 10 Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, Iwahashi H, Yamagata K, Waguri M, Nanmo T, Uno S, Nakajima H, Namba M, Kawata S, Miyagawa J I, Matsuzawa Y. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.  Diabetes. 2001;  50 1269-1273
• 11 Kolb-Bachofen V, Schraermeyer U, Hoppe T, Hanenberg H, Kolb H. Diabetes manifestation in BB rats is preceded by pan-pancreatic presence of activated inflammatory macrophages.  Pancreas. 1992;  7 578-584
• 12 Liang P, Pardee A B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.  Science. 1992;  257 967-971
• 13 Makino S, Tochino Y. The spontaneously non-obese-diabetic mouse.  Exp Anim. 1978;  27 27-29
• 14 Panicot L, Mas E, Thivolet C, Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes.  Diabetes. 1999;  48 2316-2323
• 15 Papaccio G, Chieffi-Baccari G, Mezzogiorno V, Esposito V. Extraislet infiltration in NOD mouse pancreas: observations after immunomodulation.  Pancreas. 1993;  8 459-464
• 16 Petkov P M, Kim K, Sandhu J, Shafritz D A, Dabeva M D. Identification of differentially expressed genes in epithelial stem/progenitor cells of fetal rat liver.  Genomics. 2000;  68 197-209
• 17 Rabinowe S L, Eisenbarth G S. Type I diabetes mellitus: a chronic autoimmune disease?.  Pediatr Clin North Am. 1984;  31 531-543
• 18 Rani T S, Siraj M, Ishaq M, Khan G A. Low trypsin levels in type-1 diabetes: an index of low exocrine output.  J Assoc Physicians India. 2000;  48 454 -
• 19 Rebrikov D V, Britanova O V, Gurskaya N G, Lukyanov K A, Tarabykin V S, Lukyanov S A. Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization.  Nucleic Acids Res. 2000;  28 E90
• 20 Robinson C P, Yamachika S, Alford C E, Cooper C, Pichardo E L, Shah N, Peck A B, Humphreys-Beher M G. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome.  Proc Natl Acad Sci U S A. 1997;  94 5767-5771
• 21 Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4.  Diabetologia. 1994;  37 1154-1158
• 22 Rothe H, O'Hara Jr R M. Martin S, Kolb H. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.  Diabetologia. 1997;  40 641-646
• 23 Sanchez D, Baeza N, Blouin R, Devaux C, Grondin G, Mabrouk K, Guy-Crotte O, Figarella C. Overexpression of the reg gene in non-obese diabetic mouse pancreas during active diabetogenesis is restricted to exocrine tissue.  J Histochem Cytochem. 2000;  48 1401-1410
• 24 Talaat A M, Howard S T, Hale W, Lyons R, Garner H, Johnston S A. Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis.  Nucleic Acids Res. 2002;  30 e104
• 25 Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessment of DNA microarrays-comparison with Northern blot analyses.  Genomics. 2001;  71 34-39
• 26 Taniguchi T, Seko S, Okamoto M, Hamasaki A, Ueno H, Inoue F, Nishida O, Miyake N, Mizumoto T. Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas.  Diabetes Care. 2000;  23 1592-1594
• 27 von Stein O D, Thies W G, Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes.  Nucleic Acids Res. 1997;  25 2598-2602
• 28 Waguri M, Hanafusa T, Itoh N, Miyagawa J, Imagawa A, Kuwajima M, Kono N, Matsuzawa Y. Histopathologic study of the pancreas shows a characteristic lymphocytic infiltration in Japanese patients with IDDM.  Endocr J. 1997;  44 23-33

1 Both authors contributed equally to this paper.